Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis☆
References (17)
- et al.
Endoscopic studies of nabumetone in patients with rheumatoid arthritis: a comparative endoscopic and histologic evaluation
Am J Med
(1987) Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy
Am J Med
(1987)- et al.
Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone
Am J Med
(1987) - et al.
Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin
Am J Med
(1987) - et al.
Six-month multicenter study comparing nabumetone with naproxen in the treatment of osteoarthritis
Am J Med
(1987) - et al.
Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis: nabumetone versus naproxen, a double-blind parallel study
Am J Med
(1987) - et al.
Comparative gastrointestinal loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr)
J Clin Pharmacol
(1989) - et al.
Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults
Am J Med
(1987)
There are more references available in the full text version of this article.
Cited by (4)
Pharmacologic management of common musculoskeletal disorders in women
1997, Journal of Nurse-MidwiferyNaumetone induces less gastrointestinal mucosal changes than diclofenac retard
1999, Clinical RheumatologyNabumetone compared with Ibuprofen and a weighted NSAID combination: An economic evaluation
1998, Journal of Medical Economics
- ☆
This work was supported by SmithKline Beecham Pharmaceuticals.
Copyright © 1993 Published by Excerpta Medica Inc.